{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:33:53Z","timestamp":1791304433860,"version":"4.3.1"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T00:00:00Z","timestamp":1465344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R43AI098743"],"award-info":[{"award-number":["R43AI098743"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0157061","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T13:48:41Z","timestamp":1465393721000},"page":"e0157061","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures"],"prefix":"10.1371","volume":"11","author":[{"given":"Priya","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjula","family":"Gunawardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Churchman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuong T.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Fanter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Butkyavichene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M.","family":"McNicholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M.","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. Global Report: UNAIDS report on the global AIDS epidemic 2013 Geneva: UNAIDS, 2013 November. Report No.: ISBN 978-92-9253-032-7."},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.antiviral.2013.06.021","article-title":"Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned","volume":"99","author":"DR Friend","year":"2013","journal-title":"Antiviral Res"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40265-013-0024-4","article-title":"Emtricitabine\/tenofovir disoproxil fumarate: a review of its use in HIV-1 pre-exposure prophylaxis","volume":"73","author":"GL Plosker","year":"2013","journal-title":"Drugs"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"JM Baeten","year":"2012","journal-title":"The New England journal of medicine"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.antiviral.2009.10.013","article-title":"Development of topical microbicides to prevent the sexual transmission of HIV","volume":"85","author":"RW Buckheit Jr.","year":"2010","journal-title":"Antiviral Res"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(08)70254-8","article-title":"Vaginal microbicides and the prevention of HIV transmission","volume":"8","author":"B Cutler","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/COH.0b013e328358e484","article-title":"Animal models of antiretroviral prophylaxis for HIV prevention","volume":"7","author":"JG Garcia-Lerma","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"ref8","first-page":"221","article-title":"Microbicide Vaginal Rings. Drug Delivery and Development of Anti-HIV Microbicides","author":"JAB Moss","year":"2014"},{"issue":"4","key":"ref9","first-page":"295","article-title":"Animal models for microbicide safety and efficacy testing","volume":"8","author":"RS Veazey","year":"2013","journal-title":"Curr Opin HIV AIDS"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e4879","DOI":"10.1136\/bmj.e4879","article-title":"FDA approves first drug to prevent HIV infection","volume":"345","author":"B Roehr","year":"2012","journal-title":"Bmj"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11904-014-0253-5","article-title":"Antiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxis","volume":"12","author":"DS Krakower","year":"2015","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"MC Thigpen","year":"2012","journal-title":"N Engl J Med"},{"issue":"27","key":"ref13","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"RM Grant","year":"2010","journal-title":"The New England journal of medicine"},{"key":"ref14","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","author":"S McCormack","year":"2015","journal-title":"Lancet"},{"issue":"23","key":"ref15","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection","volume":"373","author":"JM Molina","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/cid\/civ778","article-title":"No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting","volume":"61","author":"JE Volk","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"9883","key":"ref17","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"K Choopanya","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1402269","article-title":"Tenofovir-based preexposure prophylaxis for HIV infection among African women","volume":"372","author":"JM Marrazzo","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"L Van Damme","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/QAI.0000000000000607","article-title":"Genital Tenofovir Concentrations Correlate With Protection Against HIV Infection in the CAPRISA 004 Trial: Importance of Adherence for Microbicide Effectiveness","volume":"69","author":"AD Kashuba","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5996","key":"ref21","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Karim Q Abdool","year":"2010","journal-title":"Science"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/S2352-3018(15)00046-6","article-title":"Antiretroviral gels: facing the FACTS","volume":"2","year":"2015","journal-title":"The Lancet HIV"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s13346-015-0227-1","article-title":"Vaginal deployment and tenofovir delivery by microbicide gels","volume":"5","author":"Y Gao","year":"2015","journal-title":"Drug Deliv Transl Res"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40265-015-0355-4","article-title":"Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges","volume":"75","author":"DS Krakower","year":"2015","journal-title":"Drugs"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"e114700","DOI":"10.1371\/journal.pone.0114700","article-title":"High interest in a long-acting injectable formulation of pre-exposure prophylaxis for HIV in young men who have sex with men in NYC: a P18 cohort substudy","volume":"9","author":"K Meyers","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"ref26","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1128\/AAC.02871-14","article-title":"Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model","volume":"58","author":"JA Moss","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/jps.23208","article-title":"An intravaginal ring for the simultaneous delivery of multiple drugs","volume":"101","author":"MM Baum","year":"2012","journal-title":"J Pharm Sci"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/QAD.0b013e3283509abb","article-title":"Tenofovir and tenofovir disoproxil fumarate pharmacokinetics from intravaginal rings","volume":"26","author":"JA Moss","year":"2012","journal-title":"Aids"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.05662-11","article-title":"Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring","volume":"56","author":"JA Moss","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1128\/AAC.00547-13","article-title":"Pharmacokinetics of a multipurpose pod-intravaginal ring simultaneously delivering five drugs in an ovine model","volume":"57","author":"JA Moss","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","unstructured":"FDA. Guidance for industry: bioanalytical method validation Rockville MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM); 2001 [updated May]. 22]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf\" xlink:type=\"simple\">http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm070107.pdf<\/ext-link>."},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0010-7824(99)00010-4","article-title":"A vaginal fluid simulant","volume":"59","author":"DH Owen","year":"1999","journal-title":"Contraception"},{"issue":"7","key":"ref33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1086\/507306","article-title":"Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges","volume":"194","author":"S Subbarao","year":"2006","journal-title":"J Infect Dis"},{"issue":"11","key":"ref34","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1128\/AAC.01198-12","article-title":"Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques","volume":"56","author":"JA Moss","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1600-0684.2009.00354.x","article-title":"Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates","volume":"38","author":"N Promadej-Lanier","year":"2009","journal-title":"J Med Primatol"},{"issue":"11","key":"ref36","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1002\/jps.24154","article-title":"An intravaginal ring for the sustained delivery of antibodies","volume":"103","author":"M Gunawardana","year":"2014","journal-title":"J Pharm Sci"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1128\/AAC.02114-13","article-title":"Competitive fitness assays indicate that the E138A substitution in HIV-1 reverse transcriptase decreases in vitro susceptibility to emtricitabine","volume":"58","author":"N Sluis-Cremer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"9787","key":"ref38","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(11)60878-7","article-title":"Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women","volume":"378","author":"SS Karim","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"ref39","doi-asserted-by":"crossref","first-page":"e50632","DOI":"10.1371\/journal.pone.0050632","article-title":"Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen","volume":"7","author":"J Radzio","year":"2012","journal-title":"PLoS One"},{"issue":"40","key":"ref40","doi-asserted-by":"crossref","first-page":"16145","DOI":"10.1073\/pnas.1311355110","article-title":"Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges","volume":"110","author":"JM Smith","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAI.0b013e318220ebd3","article-title":"High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques","volume":"57","author":"SA Vishwanathan","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/jmp.12124","article-title":"SHIV susceptibility changes during the menstrual cycle of pigtail macaques","volume":"43","author":"EN Kersh","year":"2014","journal-title":"J Med Primatol"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/jac\/dkq447","article-title":"Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection","volume":"66","author":"PL Anderson","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1089\/aid.2013.0044","article-title":"Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue","volume":"29","author":"NA Louissaint","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/JVI.05842-11","article-title":"Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue","volume":"86","author":"C Dobard","year":"2012","journal-title":"J Virol"},{"issue":"14","key":"ref46","first-page":"14ra4","article-title":"Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection","volume":"2","author":"JG Garcia-Lerma","year":"2010","journal-title":"Sci Transl Med"},{"issue":"20","key":"ref47","doi-asserted-by":"crossref","first-page":"10358","DOI":"10.1128\/JVI.01073-09","article-title":"Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine","volume":"83","author":"UM Parikh","year":"2009","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-4690-6-44","article-title":"The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study","volume":"6","author":"JY Feng","year":"2009","journal-title":"Retrovirology"},{"issue":"10","key":"ref49","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1128\/AAC.03591-14","article-title":"The combined anti-HIV-1 activities of emtricitabine and tenofovir plus the integrase inhibitor elvitegravir or raltegravir show high levels of synergy in vitro","volume":"58","author":"R Kulkarni","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ijpharm.2015.09.028","article-title":"An intravaginal ring for the sustained delivery of tenofovir disoproxil fumarate","volume":"495","author":"MM Baum","year":"2015","journal-title":"International journal of pharmaceutics"},{"issue":"4","key":"ref51","article-title":"Impact of Pill Sharing on Drug Resistance Due to a Wide-Scale Oral Prep Intervention in Generalized Epidemics","volume":"5","author":"D Dimitrov","year":"2012","journal-title":"J AIDS Clin Res"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1093\/jac\/dku162","article-title":"Tenofovir diphosphate concentrations and prophylactic effect in a macaque model of rectal simian HIV transmission","volume":"69","author":"PL Anderson","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 3","key":"ref53","first-page":"S43","article-title":"Female-controlled methods to prevent sexual transmission of HIV","volume":"10","author":"CJ Elias","year":"1996","journal-title":"Aids"},{"issue":"10","key":"ref54","first-page":"1231","article-title":"Microbicides in the prevention of HIV infection: current status and future directions","volume":"70","author":"J Nuttall","year":"2010","journal-title":"Drugs"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11096-013-9861-1","article-title":"Adherence challenges with drugs for pre-exposure prophylaxis to prevent HIV infection","volume":"36","author":"TN Gengiah","year":"2014","journal-title":"Int J Clin Pharm"},{"issue":"227","key":"ref56","doi-asserted-by":"crossref","first-page":"227ra35","DOI":"10.1126\/scitranslmed.3007701","article-title":"Postexposure protection of macaques from vaginal SHIV infection by topical integrase inhibitors","volume":"6","author":"C Dobard","year":"2014","journal-title":"Sci Transl Med"},{"issue":"Suppl 1","key":"ref57","doi-asserted-by":"crossref","first-page":"A13","DOI":"10.1089\/aid.2014.5013a.abstract","article-title":"Rectal Specific Gels Containing Maraviroc and\/or Tenofovir Protect against Rectal SHIV Transmission in a Macaque Model","volume":"30","author":"C Dobard","year":"2014","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"2","key":"ref58","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0050028","article-title":"Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir","volume":"5","author":"JG Garcia-Lerma","year":"2008","journal-title":"PLoS Med"},{"issue":"1","key":"ref59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000000402","article-title":"Tenofovir disoproxil fumarate intravaginal ring protects high-dose depot medroxyprogesterone acetate-treated macaques from multiple SHIV exposures","volume":"68","author":"JM Smith","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0684.2011.00488.x","article-title":"Development of a pigtail macaque model of sexually transmitted infection\/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3)","volume":"40","author":"T Henning","year":"2011","journal-title":"J Med Primatol"},{"issue":"8","key":"ref61","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/infdis\/jiu240","article-title":"Increased susceptibility to vaginal simian\/human immunodeficiency virus transmission in pig-tailed macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis","volume":"210","author":"TR Henning","year":"2014","journal-title":"J Infect Dis"},{"key":"ref62"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0157061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:00:18Z","timestamp":1540335618000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0157061"}},"subtitle":[],"editor":[{"given":"Cheryl A.","family":"Stoddart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":62,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0157061","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]}}}